Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis - Merkel, P. A.; Silliman, N. P.; Clements, P. J.; Denton, C. P.; Furst, D. E.; Mayes, M. D.; Pope, J. E.; Polisson, R. P.; Streisand, J. B.; Seibold, J. R. (Arthritis & rheumatology (Hoboken, N.J.), 2012)
Keywords: Adult; Biological and medical sciences; Clinical outcomes; Clinical trials; Clinical Trials as Topic; Diseases of the osteoarticular system; Female; Humans; Male; Medical sciences; Middle Aged; Outcome Assessment, Health Care; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Scleroderma; Scleroderma, Diffuse - drug therapy; Treatment Outcome; Diffuse; Human; Immunopathology; Connective tissue disease; Skin disease; Prognosis; Rheumatology; Autoimmune disease; Systemic disease; Clinical trial; Skin; Predictive factor; Scleroderma